img

Global Oral Solid Dosage Formulation Development Service Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Oral Solid Dosage Formulation Development Service Market Insights, Forecast to 2034

Market Analysis and InsightsGlobal Oral Solid Dosage Formulation Development Service Market
Global Oral Solid Dosage Formulation Development Service market is expected to reach to US$ 219.3 million in 2023, with a positive growth of %, compared with US$ 205.6 million in 2022. Backed with the increasing demand from downstream industries, Oral Solid Dosage Formulation Development Service industry is evaluated to reach US$ 268.1 million in 2033. The CAGR will be 3.4% during 2023 to 2033.
Globally, Oral Solid Dosage Formulation Development Service key companies include Pfizer, Evonik Industries, Societal, Aurigene Pharmaceutical Services, Thermo Fisher Scientific, Skyepharma Production, Recipeharm, UPM Pharmaceuticals and Crystal Pharmatech, etc. Pfizer, Evonik Industries, Societal are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Oral Solid Dosage Formulation Development Service were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Oral Solid Dosage Formulation Development Service market and estimated to attract more attentions from industry insiders and investors.
Oral Solid Dosage Formulation Development Service can be divided into Tablet, Capsule and Powder,, etc. Tablet is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
Oral Solid Dosage Formulation Development Service is widely used in various fields, such as SMEs and Large Enterprises, etc. SMEs provides greatest supports to the Oral Solid Dosage Formulation Development Service industry development. In 2022, global % revenue of Oral Solid Dosage Formulation Development Service went into SMEs filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Oral Solid Dosage Formulation Development Service market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Oral Solid Dosage Formulation Development Service market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Pfizer
Evonik Industries
Societal
Aurigene Pharmaceutical Services
Thermo Fisher Scientific
Skyepharma Production
Recipeharm
UPM Pharmaceuticals
Crystal Pharmatech
Almac Group
Alcami
Lonza
Catalent
Ascendia
Segment by Type
Tablet
Capsule
Powder

Segment by Application


SMEs
Large Enterprises
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Oral Solid Dosage Formulation Development Service introduction, etc. Oral Solid Dosage Formulation Development Service Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Oral Solid Dosage Formulation Development Service
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oral Solid Dosage Formulation Development Service Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Tablet
1.2.3 Capsule
1.2.4 Powder
1.3 Market by Application
1.3.1 Global Oral Solid Dosage Formulation Development Service Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 SMEs
1.3.3 Large Enterprises
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oral Solid Dosage Formulation Development Service Market Perspective (2018-2033)
2.2 Global Oral Solid Dosage Formulation Development Service Growth Trends by Region
2.2.1 Oral Solid Dosage Formulation Development Service Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Oral Solid Dosage Formulation Development Service Historic Market Size by Region (2018-2023)
2.2.3 Oral Solid Dosage Formulation Development Service Forecasted Market Size by Region (2024-2033)
2.3 Oral Solid Dosage Formulation Development Service Market Dynamics
2.3.1 Oral Solid Dosage Formulation Development Service Industry Trends
2.3.2 Oral Solid Dosage Formulation Development Service Market Drivers
2.3.3 Oral Solid Dosage Formulation Development Service Market Challenges
2.3.4 Oral Solid Dosage Formulation Development Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Oral Solid Dosage Formulation Development Service by Players
3.1.1 Global Oral Solid Dosage Formulation Development Service Revenue by Players (2018-2023)
3.1.2 Global Oral Solid Dosage Formulation Development Service Revenue Market Share by Players (2018-2023)
3.2 Global Oral Solid Dosage Formulation Development Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Oral Solid Dosage Formulation Development Service, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Oral Solid Dosage Formulation Development Service Market Concentration Ratio
3.4.1 Global Oral Solid Dosage Formulation Development Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oral Solid Dosage Formulation Development Service Revenue in 2022
3.5 Global Key Players of Oral Solid Dosage Formulation Development Service Head office and Area Served
3.6 Global Key Players of Oral Solid Dosage Formulation Development Service, Product and Application
3.7 Global Key Players of Oral Solid Dosage Formulation Development Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Oral Solid Dosage Formulation Development Service Breakdown Data by Type
4.1 Global Oral Solid Dosage Formulation Development Service Historic Market Size by Type (2018-2023)
4.2 Global Oral Solid Dosage Formulation Development Service Forecasted Market Size by Type (2024-2033)
5 Oral Solid Dosage Formulation Development Service Breakdown Data by Application
5.1 Global Oral Solid Dosage Formulation Development Service Historic Market Size by Application (2018-2023)
5.2 Global Oral Solid Dosage Formulation Development Service Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Oral Solid Dosage Formulation Development Service Market Size (2018-2033)
6.2 North America Oral Solid Dosage Formulation Development Service Market Size by Type
6.2.1 North America Oral Solid Dosage Formulation Development Service Market Size by Type (2018-2023)
6.2.2 North America Oral Solid Dosage Formulation Development Service Market Size by Type (2024-2033)
6.2.3 North America Oral Solid Dosage Formulation Development Service Market Share by Type (2018-2033)
6.3 North America Oral Solid Dosage Formulation Development Service Market Size by Application
6.3.1 North America Oral Solid Dosage Formulation Development Service Market Size by Application (2018-2023)
6.3.2 North America Oral Solid Dosage Formulation Development Service Market Size by Application (2024-2033)
6.3.3 North America Oral Solid Dosage Formulation Development Service Market Share by Application (2018-2033)
6.4 North America Oral Solid Dosage Formulation Development Service Market Size by Country
6.4.1 North America Oral Solid Dosage Formulation Development Service Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Oral Solid Dosage Formulation Development Service Market Size by Country (2018-2023)
6.4.3 North America Oral Solid Dosage Formulation Development Service Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Oral Solid Dosage Formulation Development Service Market Size (2018-2033)
7.2 Europe Oral Solid Dosage Formulation Development Service Market Size by Type
7.2.1 Europe Oral Solid Dosage Formulation Development Service Market Size by Type (2018-2023)
7.2.2 Europe Oral Solid Dosage Formulation Development Service Market Size by Type (2024-2033)
7.2.3 Europe Oral Solid Dosage Formulation Development Service Market Share by Type (2018-2033)
7.3 Europe Oral Solid Dosage Formulation Development Service Market Size by Application
7.3.1 Europe Oral Solid Dosage Formulation Development Service Market Size by Application (2018-2023)
7.3.2 Europe Oral Solid Dosage Formulation Development Service Market Size by Application (2024-2033)
7.3.3 Europe Oral Solid Dosage Formulation Development Service Market Share by Application (2018-2033)
7.4 Europe Oral Solid Dosage Formulation Development Service Market Size by Country
7.4.1 Europe Oral Solid Dosage Formulation Development Service Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Oral Solid Dosage Formulation Development Service Market Size by Country (2018-2023)
7.4.3 Europe Oral Solid Dosage Formulation Development Service Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Oral Solid Dosage Formulation Development Service Market Size (2018-2033)
8.2 China Oral Solid Dosage Formulation Development Service Market Size by Type
8.2.1 China Oral Solid Dosage Formulation Development Service Market Size by Type (2018-2023)
8.2.2 China Oral Solid Dosage Formulation Development Service Market Size by Type (2024-2033)
8.2.3 China Oral Solid Dosage Formulation Development Service Market Share by Type (2018-2033)
8.3 China Oral Solid Dosage Formulation Development Service Market Size by Application
8.3.1 China Oral Solid Dosage Formulation Development Service Market Size by Application (2018-2023)
8.3.2 China Oral Solid Dosage Formulation Development Service Market Size by Application (2024-2033)
8.3.3 China Oral Solid Dosage Formulation Development Service Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Oral Solid Dosage Formulation Development Service Market Size (2018-2033)
9.2 Asia Oral Solid Dosage Formulation Development Service Market Size by Type
9.2.1 Asia Oral Solid Dosage Formulation Development Service Market Size by Type (2018-2023)
9.2.2 Asia Oral Solid Dosage Formulation Development Service Market Size by Type (2024-2033)
9.2.3 Asia Oral Solid Dosage Formulation Development Service Market Share by Type (2018-2033)
9.3 Asia Oral Solid Dosage Formulation Development Service Market Size by Application
9.3.1 Asia Oral Solid Dosage Formulation Development Service Market Size by Application (2018-2023)
9.3.2 Asia Oral Solid Dosage Formulation Development Service Market Size by Application (2024-2033)
9.3.3 Asia Oral Solid Dosage Formulation Development Service Market Share by Application (2018-2033)
9.4 Asia Oral Solid Dosage Formulation Development Service Market Size by Region
9.4.1 Asia Oral Solid Dosage Formulation Development Service Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Oral Solid Dosage Formulation Development Service Market Size by Region (2018-2023)
9.4.3 Asia Oral Solid Dosage Formulation Development Service Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Oral Solid Dosage Formulation Development Service Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Oral Solid Dosage Formulation Development Service Market Size by Type
10.2.1 Middle East, Africa, and Latin America Oral Solid Dosage Formulation Development Service Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Oral Solid Dosage Formulation Development Service Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Oral Solid Dosage Formulation Development Service Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Oral Solid Dosage Formulation Development Service Market Size by Application
10.3.1 Middle East, Africa, and Latin America Oral Solid Dosage Formulation Development Service Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Oral Solid Dosage Formulation Development Service Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Oral Solid Dosage Formulation Development Service Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Oral Solid Dosage Formulation Development Service Market Size by Country
10.4.1 Middle East, Africa, and Latin America Oral Solid Dosage Formulation Development Service Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Oral Solid Dosage Formulation Development Service Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Oral Solid Dosage Formulation Development Service Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Oral Solid Dosage Formulation Development Service Introduction
11.1.4 Pfizer Revenue in Oral Solid Dosage Formulation Development Service Business (2018-2023)
11.1.5 Pfizer Recent Developments
11.2 Evonik Industries
11.2.1 Evonik Industries Company Details
11.2.2 Evonik Industries Business Overview
11.2.3 Evonik Industries Oral Solid Dosage Formulation Development Service Introduction
11.2.4 Evonik Industries Revenue in Oral Solid Dosage Formulation Development Service Business (2018-2023)
11.2.5 Evonik Industries Recent Developments
11.3 Societal
11.3.1 Societal Company Details
11.3.2 Societal Business Overview
11.3.3 Societal Oral Solid Dosage Formulation Development Service Introduction
11.3.4 Societal Revenue in Oral Solid Dosage Formulation Development Service Business (2018-2023)
11.3.5 Societal Recent Developments
11.4 Aurigene Pharmaceutical Services
11.4.1 Aurigene Pharmaceutical Services Company Details
11.4.2 Aurigene Pharmaceutical Services Business Overview
11.4.3 Aurigene Pharmaceutical Services Oral Solid Dosage Formulation Development Service Introduction
11.4.4 Aurigene Pharmaceutical Services Revenue in Oral Solid Dosage Formulation Development Service Business (2018-2023)
11.4.5 Aurigene Pharmaceutical Services Recent Developments
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Details
11.5.2 Thermo Fisher Scientific Business Overview
11.5.3 Thermo Fisher Scientific Oral Solid Dosage Formulation Development Service Introduction
11.5.4 Thermo Fisher Scientific Revenue in Oral Solid Dosage Formulation Development Service Business (2018-2023)
11.5.5 Thermo Fisher Scientific Recent Developments
11.6 Skyepharma Production
11.6.1 Skyepharma Production Company Details
11.6.2 Skyepharma Production Business Overview
11.6.3 Skyepharma Production Oral Solid Dosage Formulation Development Service Introduction
11.6.4 Skyepharma Production Revenue in Oral Solid Dosage Formulation Development Service Business (2018-2023)
11.6.5 Skyepharma Production Recent Developments
11.7 Recipeharm
11.7.1 Recipeharm Company Details
11.7.2 Recipeharm Business Overview
11.7.3 Recipeharm Oral Solid Dosage Formulation Development Service Introduction
11.7.4 Recipeharm Revenue in Oral Solid Dosage Formulation Development Service Business (2018-2023)
11.7.5 Recipeharm Recent Developments
11.8 UPM Pharmaceuticals
11.8.1 UPM Pharmaceuticals Company Details
11.8.2 UPM Pharmaceuticals Business Overview
11.8.3 UPM Pharmaceuticals Oral Solid Dosage Formulation Development Service Introduction
11.8.4 UPM Pharmaceuticals Revenue in Oral Solid Dosage Formulation Development Service Business (2018-2023)
11.8.5 UPM Pharmaceuticals Recent Developments
11.9 Crystal Pharmatech
11.9.1 Crystal Pharmatech Company Details
11.9.2 Crystal Pharmatech Business Overview
11.9.3 Crystal Pharmatech Oral Solid Dosage Formulation Development Service Introduction
11.9.4 Crystal Pharmatech Revenue in Oral Solid Dosage Formulation Development Service Business (2018-2023)
11.9.5 Crystal Pharmatech Recent Developments
11.10 Almac Group
11.10.1 Almac Group Company Details
11.10.2 Almac Group Business Overview
11.10.3 Almac Group Oral Solid Dosage Formulation Development Service Introduction
11.10.4 Almac Group Revenue in Oral Solid Dosage Formulation Development Service Business (2018-2023)
11.10.5 Almac Group Recent Developments
11.11 Alcami
11.11.1 Alcami Company Details
11.11.2 Alcami Business Overview
11.11.3 Alcami Oral Solid Dosage Formulation Development Service Introduction
11.11.4 Alcami Revenue in Oral Solid Dosage Formulation Development Service Business (2018-2023)
11.11.5 Alcami Recent Developments
11.12 Lonza
11.12.1 Lonza Company Details
11.12.2 Lonza Business Overview
11.12.3 Lonza Oral Solid Dosage Formulation Development Service Introduction
11.12.4 Lonza Revenue in Oral Solid Dosage Formulation Development Service Business (2018-2023)
11.12.5 Lonza Recent Developments
11.13 Catalent
11.13.1 Catalent Company Details
11.13.2 Catalent Business Overview
11.13.3 Catalent Oral Solid Dosage Formulation Development Service Introduction
11.13.4 Catalent Revenue in Oral Solid Dosage Formulation Development Service Business (2018-2023)
11.13.5 Catalent Recent Developments
11.14 Ascendia
11.14.1 Ascendia Company Details
11.14.2 Ascendia Business Overview
11.14.3 Ascendia Oral Solid Dosage Formulation Development Service Introduction
11.14.4 Ascendia Revenue in Oral Solid Dosage Formulation Development Service Business (2018-2023)
11.14.5 Ascendia Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Oral Solid Dosage Formulation Development Service Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Tablet
Table 3. Key Players of Capsule
Table 4. Key Players of Powder
Table 5. Global Oral Solid Dosage Formulation Development Service Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 6. Global Oral Solid Dosage Formulation Development Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Oral Solid Dosage Formulation Development Service Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Oral Solid Dosage Formulation Development Service Market Share by Region (2018-2023)
Table 9. Global Oral Solid Dosage Formulation Development Service Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Oral Solid Dosage Formulation Development Service Market Share by Region (2024-2033)
Table 11. Oral Solid Dosage Formulation Development Service Market Trends
Table 12. Oral Solid Dosage Formulation Development Service Market Drivers
Table 13. Oral Solid Dosage Formulation Development Service Market Challenges
Table 14. Oral Solid Dosage Formulation Development Service Market Restraints
Table 15. Global Oral Solid Dosage Formulation Development Service Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Oral Solid Dosage Formulation Development Service Revenue Share by Players (2018-2023)
Table 17. Global Top Oral Solid Dosage Formulation Development Service by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Solid Dosage Formulation Development Service as of 2022)
Table 18. Global Oral Solid Dosage Formulation Development Service Industry Ranking 2021 VS 2022 VS 2023
Table 19. Global 5 Largest Players Market Share by Oral Solid Dosage Formulation Development Service Revenue (CR5 and HHI) & (2018-2023)
Table 20. Global Key Players of Oral Solid Dosage Formulation Development Service, Headquarters and Area Served
Table 21. Global Key Players of Oral Solid Dosage Formulation Development Service, Product and Application
Table 22. Global Key Players of Oral Solid Dosage Formulation Development Service, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Oral Solid Dosage Formulation Development Service Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Oral Solid Dosage Formulation Development Service Revenue Market Share by Type (2018-2023)
Table 26. Global Oral Solid Dosage Formulation Development Service Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Oral Solid Dosage Formulation Development Service Revenue Market Share by Type (2024-2033)
Table 28. Global Oral Solid Dosage Formulation Development Service Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Oral Solid Dosage Formulation Development Service Revenue Share by Application (2018-2023)
Table 30. Global Oral Solid Dosage Formulation Development Service Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Oral Solid Dosage Formulation Development Service Revenue Share by Application (2024-2033)
Table 32. North America Oral Solid Dosage Formulation Development Service Market Size by Type (2018-2023) & (US$ Million)
Table 33. North America Oral Solid Dosage Formulation Development Service Market Size by Type (2024-2033) & (US$ Million)
Table 34. North America Oral Solid Dosage Formulation Development Service Market Size by Application (2018-2023) & (US$ Million)
Table 35. North America Oral Solid Dosage Formulation Development Service Market Size by Application (2024-2033) & (US$ Million)
Table 36. North America Oral Solid Dosage Formulation Development Service Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. North America Oral Solid Dosage Formulation Development Service Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America Oral Solid Dosage Formulation Development Service Market Size by Country (2024-2033) & (US$ Million)
Table 39. Europe Oral Solid Dosage Formulation Development Service Market Size by Type (2018-2023) & (US$ Million)
Table 40. Europe Oral Solid Dosage Formulation Development Service Market Size by Type (2024-2033) & (US$ Million)
Table 41. Europe Oral Solid Dosage Formulation Development Service Market Size by Application (2018-2023) & (US$ Million)
Table 42. Europe Oral Solid Dosage Formulation Development Service Market Size by Application (2024-2033) & (US$ Million)
Table 43. Europe Oral Solid Dosage Formulation Development Service Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Europe Oral Solid Dosage Formulation Development Service Market Size by Country (2018-2023) & (US$ Million)
Table 45. Europe Oral Solid Dosage Formulation Development Service Market Size by Country (2024-2033) & (US$ Million)
Table 46. China Oral Solid Dosage Formulation Development Service Market Size by Type (2018-2023) & (US$ Million)
Table 47. China Oral Solid Dosage Formulation Development Service Market Size by Type (2024-2033) & (US$ Million)
Table 48. China Oral Solid Dosage Formulation Development Service Market Size by Application (2018-2023) & (US$ Million)
Table 49. China Oral Solid Dosage Formulation Development Service Market Size by Application (2024-2033) & (US$ Million)
Table 50. Asia Oral Solid Dosage Formulation Development Service Market Size by Type (2018-2023) & (US$ Million)
Table 51. Asia Oral Solid Dosage Formulation Development Service Market Size by Type (2024-2033) & (US$ Million)
Table 52. Asia Oral Solid Dosage Formulation Development Service Market Size by Application (2018-2023) & (US$ Million)
Table 53. Asia Oral Solid Dosage Formulation Development Service Market Size by Application (2024-2033) & (US$ Million)
Table 54. Asia Oral Solid Dosage Formulation Development Service Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 55. Asia Oral Solid Dosage Formulation Development Service Market Size by Region (2018-2023) & (US$ Million)
Table 56. Asia Oral Solid Dosage Formulation Development Service Market Size by Region (2024-2033) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Oral Solid Dosage Formulation Development Service Market Size by Type (2018-2023) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Oral Solid Dosage Formulation Development Service Market Size by Type (2024-2033) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Oral Solid Dosage Formulation Development Service Market Size by Application (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Oral Solid Dosage Formulation Development Service Market Size by Application (2024-2033) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Oral Solid Dosage Formulation Development Service Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 62. Middle East, Africa, and Latin America Oral Solid Dosage Formulation Development Service Market Size by Country (2018-2023) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Oral Solid Dosage Formulation Development Service Market Size by Country (2024-2033) & (US$ Million)
Table 64. Pfizer Company Details
Table 65. Pfizer Business Overview
Table 66. Pfizer Oral Solid Dosage Formulation Development Service Product
Table 67. Pfizer Revenue in Oral Solid Dosage Formulation Development Service Business (2018-2023) & (US$ Million)
Table 68. Pfizer Recent Developments
Table 69. Evonik Industries Company Details
Table 70. Evonik Industries Business Overview
Table 71. Evonik Industries Oral Solid Dosage Formulation Development Service Product
Table 72. Evonik Industries Revenue in Oral Solid Dosage Formulation Development Service Business (2018-2023) & (US$ Million)
Table 73. Evonik Industries Recent Developments
Table 74. Societal Company Details
Table 75. Societal Business Overview
Table 76. Societal Oral Solid Dosage Formulation Development Service Product
Table 77. Societal Revenue in Oral Solid Dosage Formulation Development Service Business (2018-2023) & (US$ Million)
Table 78. Societal Recent Developments
Table 79. Aurigene Pharmaceutical Services Company Details
Table 80. Aurigene Pharmaceutical Services Business Overview
Table 81. Aurigene Pharmaceutical Services Oral Solid Dosage Formulation Development Service Product
Table 82. Aurigene Pharmaceutical Services Revenue in Oral Solid Dosage Formulation Development Service Business (2018-2023) & (US$ Million)
Table 83. Aurigene Pharmaceutical Services Recent Developments
Table 84. Thermo Fisher Scientific Company Details
Table 85. Thermo Fisher Scientific Business Overview
Table 86. Thermo Fisher Scientific Oral Solid Dosage Formulation Development Service Product
Table 87. Thermo Fisher Scientific Revenue in Oral Solid Dosage Formulation Development Service Business (2018-2023) & (US$ Million)
Table 88. Thermo Fisher Scientific Recent Developments
Table 89. Skyepharma Production Company Details
Table 90. Skyepharma Production Business Overview
Table 91. Skyepharma Production Oral Solid Dosage Formulation Development Service Product
Table 92. Skyepharma Production Revenue in Oral Solid Dosage Formulation Development Service Business (2018-2023) & (US$ Million)
Table 93. Skyepharma Production Recent Developments
Table 94. Recipeharm Company Details
Table 95. Recipeharm Business Overview
Table 96. Recipeharm Oral Solid Dosage Formulation Development Service Product
Table 97. Recipeharm Revenue in Oral Solid Dosage Formulation Development Service Business (2018-2023) & (US$ Million)
Table 98. Recipeharm Recent Developments
Table 99. UPM Pharmaceuticals Company Details
Table 100. UPM Pharmaceuticals Business Overview
Table 101. UPM Pharmaceuticals Oral Solid Dosage Formulation Development Service Product
Table 102. UPM Pharmaceuticals Revenue in Oral Solid Dosage Formulation Development Service Business (2018-2023) & (US$ Million)
Table 103. UPM Pharmaceuticals Recent Developments
Table 104. Crystal Pharmatech Company Details
Table 105. Crystal Pharmatech Business Overview
Table 106. Crystal Pharmatech Oral Solid Dosage Formulation Development Service Product
Table 107. Crystal Pharmatech Revenue in Oral Solid Dosage Formulation Development Service Business (2018-2023) & (US$ Million)
Table 108. Crystal Pharmatech Recent Developments
Table 109. Almac Group Company Details
Table 110. Almac Group Business Overview
Table 111. Almac Group Oral Solid Dosage Formulation Development Service Product
Table 112. Almac Group Revenue in Oral Solid Dosage Formulation Development Service Business (2018-2023) & (US$ Million)
Table 113. Almac Group Recent Developments
Table 114. Alcami Company Details
Table 115. Alcami Business Overview
Table 116. Alcami Oral Solid Dosage Formulation Development Service Product
Table 117. Alcami Revenue in Oral Solid Dosage Formulation Development Service Business (2018-2023) & (US$ Million)
Table 118. Alcami Recent Developments
Table 119. Lonza Company Details
Table 120. Lonza Business Overview
Table 121. Lonza Oral Solid Dosage Formulation Development Service Product
Table 122. Lonza Revenue in Oral Solid Dosage Formulation Development Service Business (2018-2023) & (US$ Million)
Table 123. Lonza Recent Developments
Table 124. Catalent Company Details
Table 125. Catalent Business Overview
Table 126. Catalent Oral Solid Dosage Formulation Development Service Product
Table 127. Catalent Revenue in Oral Solid Dosage Formulation Development Service Business (2018-2023) & (US$ Million)
Table 128. Catalent Recent Developments
Table 129. Ascendia Company Details
Table 130. Ascendia Business Overview
Table 131. Ascendia Oral Solid Dosage Formulation Development Service Product
Table 132. Ascendia Revenue in Oral Solid Dosage Formulation Development Service Business (2018-2023) & (US$ Million)
Table 133. Ascendia Recent Developments
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oral Solid Dosage Formulation Development Service Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Oral Solid Dosage Formulation Development Service Market Share by Type: 2022 VS 2033
Figure 3. Tablet Features
Figure 4. Capsule Features
Figure 5. Powder Features
Figure 6. Global Oral Solid Dosage Formulation Development Service Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 7. Global Oral Solid Dosage Formulation Development Service Market Share by Application: 2022 VS 2033
Figure 8. SMEs Case Studies
Figure 9. Large Enterprises Case Studies
Figure 10. Oral Solid Dosage Formulation Development Service Report Years Considered
Figure 11. Global Oral Solid Dosage Formulation Development Service Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Oral Solid Dosage Formulation Development Service Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Oral Solid Dosage Formulation Development Service Market Share by Region: 2022 VS 2033
Figure 14. Global Oral Solid Dosage Formulation Development Service Market Share by Players in 2022
Figure 15. Global Top Oral Solid Dosage Formulation Development Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Solid Dosage Formulation Development Service as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Oral Solid Dosage Formulation Development Service Revenue in 2022
Figure 17. North America Oral Solid Dosage Formulation Development Service Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Oral Solid Dosage Formulation Development Service Market Share by Type (2018-2033)
Figure 19. North America Oral Solid Dosage Formulation Development Service Market Share by Application (2018-2033)
Figure 20. North America Oral Solid Dosage Formulation Development Service Market Share by Country (2018-2033)
Figure 21. United States Oral Solid Dosage Formulation Development Service Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Oral Solid Dosage Formulation Development Service Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Oral Solid Dosage Formulation Development Service Market Size YoY (2018-2033) & (US$ Million)
Figure 24. Europe Oral Solid Dosage Formulation Development Service Market Share by Type (2018-2033)
Figure 25. Europe Oral Solid Dosage Formulation Development Service Market Share by Application (2018-2033)
Figure 26. Europe Oral Solid Dosage Formulation Development Service Market Share by Country (2018-2033)
Figure 27. Germany Oral Solid Dosage Formulation Development Service Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. France Oral Solid Dosage Formulation Development Service Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. U.K. Oral Solid Dosage Formulation Development Service Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Italy Oral Solid Dosage Formulation Development Service Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Russia Oral Solid Dosage Formulation Development Service Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Nordic Countries Oral Solid Dosage Formulation Development Service Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. China Oral Solid Dosage Formulation Development Service Market Size YoY (2018-2033) & (US$ Million)
Figure 34. China Oral Solid Dosage Formulation Development Service Market Share by Type (2018-2033)
Figure 35. China Oral Solid Dosage Formulation Development Service Market Share by Application (2018-2033)
Figure 36. Asia Oral Solid Dosage Formulation Development Service Market Size YoY (2018-2033) & (US$ Million)
Figure 37. Asia Oral Solid Dosage Formulation Development Service Market Share by Type (2018-2033)
Figure 38. Asia Oral Solid Dosage Formulation Development Service Market Share by Application (2018-2033)
Figure 39. Asia Oral Solid Dosage Formulation Development Service Market Share by Region (2018-2033)
Figure 40. Japan Oral Solid Dosage Formulation Development Service Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. South Korea Oral Solid Dosage Formulation Development Service Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. China Taiwan Oral Solid Dosage Formulation Development Service Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Southeast Asia Oral Solid Dosage Formulation Development Service Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. India Oral Solid Dosage Formulation Development Service Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Australia Oral Solid Dosage Formulation Development Service Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Oral Solid Dosage Formulation Development Service Market Size YoY (2018-2033) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Oral Solid Dosage Formulation Development Service Market Share by Type (2018-2033)
Figure 48. Middle East, Africa, and Latin America Oral Solid Dosage Formulation Development Service Market Share by Application (2018-2033)
Figure 49. Middle East, Africa, and Latin America Oral Solid Dosage Formulation Development Service Market Share by Country (2018-2033)
Figure 50. Brazil Oral Solid Dosage Formulation Development Service Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Mexico Oral Solid Dosage Formulation Development Service Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Turkey Oral Solid Dosage Formulation Development Service Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Saudi Arabia Oral Solid Dosage Formulation Development Service Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Israel Oral Solid Dosage Formulation Development Service Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. GCC Countries Oral Solid Dosage Formulation Development Service Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Pfizer Revenue Growth Rate in Oral Solid Dosage Formulation Development Service Business (2018-2023)
Figure 57. Evonik Industries Revenue Growth Rate in Oral Solid Dosage Formulation Development Service Business (2018-2023)
Figure 58. Societal Revenue Growth Rate in Oral Solid Dosage Formulation Development Service Business (2018-2023)
Figure 59. Aurigene Pharmaceutical Services Revenue Growth Rate in Oral Solid Dosage Formulation Development Service Business (2018-2023)
Figure 60. Thermo Fisher Scientific Revenue Growth Rate in Oral Solid Dosage Formulation Development Service Business (2018-2023)
Figure 61. Skyepharma Production Revenue Growth Rate in Oral Solid Dosage Formulation Development Service Business (2018-2023)
Figure 62. Recipeharm Revenue Growth Rate in Oral Solid Dosage Formulation Development Service Business (2018-2023)
Figure 63. UPM Pharmaceuticals Revenue Growth Rate in Oral Solid Dosage Formulation Development Service Business (2018-2023)
Figure 64. Crystal Pharmatech Revenue Growth Rate in Oral Solid Dosage Formulation Development Service Business (2018-2023)
Figure 65. Almac Group Revenue Growth Rate in Oral Solid Dosage Formulation Development Service Business (2018-2023)
Figure 66. Alcami Revenue Growth Rate in Oral Solid Dosage Formulation Development Service Business (2018-2023)
Figure 67. Lonza Revenue Growth Rate in Oral Solid Dosage Formulation Development Service Business (2018-2023)
Figure 68. Catalent Revenue Growth Rate in Oral Solid Dosage Formulation Development Service Business (2018-2023)
Figure 69. Ascendia Revenue Growth Rate in Oral Solid Dosage Formulation Development Service Business (2018-2023)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed